180 related articles for article (PubMed ID: 1887523)
1. Crystal growth of calcium oxalate in urine of stone-formers and normal controls.
Achilles W; Dekanić D; Burk M; Schalk C; Tucak A; Karner I
Urol Res; 1991; 19(3):159-64. PubMed ID: 1887523
[TBL] [Abstract][Full Text] [Related]
2. Magnesium, citrate, magnesium citrate and magnesium-alkali citrate as modulators of calcium oxalate crystallization in urine: observations in patients with recurrent idiopathic calcium urolithiasis.
Schwille PO; Schmiedl A; Herrmann U; Fan J; Gottlieb D; Manoharan M; Wipplinger J
Urol Res; 1999 Apr; 27(2):117-26. PubMed ID: 10424393
[TBL] [Abstract][Full Text] [Related]
3. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
4. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the possible role of sialic acid in calcium oxalate urolithiasis.
Yoshimura K; Yoshioka T; Miyake O; Honda M; Koide T; Okuyama A
Eur Urol; 1998; 33(1):111-5. PubMed ID: 9471052
[TBL] [Abstract][Full Text] [Related]
6. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.
Hedgepeth RC; Yang L; Resnick MI; Marengo SR
Am J Kidney Dis; 2001 Jan; 37(1):104-112. PubMed ID: 11136174
[TBL] [Abstract][Full Text] [Related]
7. Measurement of the risk of calcium oxalate crystallization in urine.
Tiselius HG
Urol Res; 1985; 13(6):297-300. PubMed ID: 4095829
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
Bek-Jensen H; Tiselius HG
Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
[TBL] [Abstract][Full Text] [Related]
10. Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?
Rodgers AL; Webber D; Hibberd B
Urolithiasis; 2015 Nov; 43(6):479-87. PubMed ID: 26198547
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcium oxalate crystallization by urinary macromolecules.
Bek-Jensen H; Tiselius HG
Urol Res; 1991; 19(3):165-9. PubMed ID: 1887524
[TBL] [Abstract][Full Text] [Related]
12. Examination of crystalluria in freshly voided urines of recurrent calcium stone formers and normal individuals using a new filter technique.
Fan J; Chandhoke PS
J Urol; 1999 May; 161(5):1685-8. PubMed ID: 10210440
[TBL] [Abstract][Full Text] [Related]
13. Crystallization kinetics of calcium oxalate in fresh, minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer.
Kavanagh JP; Nishio S; Garside J; Blacklock NJ
J Urol; 1993 Mar; 149(3):614-7. PubMed ID: 8437278
[TBL] [Abstract][Full Text] [Related]
14. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
[TBL] [Abstract][Full Text] [Related]
15. The effect of pH on the risk of calcium oxalate crystallization in urine.
Berg C; Tiselius HG
Eur Urol; 1986; 12(1):59-61. PubMed ID: 3948899
[TBL] [Abstract][Full Text] [Related]
16. Polyanionic inhibitors of calcium oxalate crystal agglomeration in urine.
Scurr DS; Latif AB; Sergeant V; Robertson WG
Proc Eur Dial Transplant Assoc; 1983; 20():440-4. PubMed ID: 6197713
[TBL] [Abstract][Full Text] [Related]
17. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.
Tiselius HG
Clin Chim Acta; 1982 Jul; 122(3):409-18. PubMed ID: 7105424
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
Murayama T; Taguchi H
Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
[TBL] [Abstract][Full Text] [Related]
19. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
20. Assessment of crystallization risk formulas in pediatric calcium stone-formers.
Sikora P; Zajaczkowska M; Hoppe B
Pediatr Nephrol; 2009 Oct; 24(10):1997-2003. PubMed ID: 19333626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
